Advanced Magnetic Resonance Imaging (MRI) Techniques: Technical Principles and Applications in Nanomedicine

In the last decades, nanotechnology has been used in a wide range of biomedical applications, both diagnostic and therapeutic. In this scenario, imaging techniques represent a fundamental tool to obtain information about the properties of nanoconstructs and their interactions with the biological env...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 14; no. 7; p. 1626
Main Authors Bruno, Federico, Granata, Vincenza, Cobianchi Bellisari, Flavia, Sgalambro, Ferruccio, Tommasino, Emanuele, Palumbo, Pierpaolo, Arrigoni, Francesco, Cozzi, Diletta, Grassi, Francesca, Brunese, Maria Chiara, Pradella, Silvia, di S Stefano, Maria Luisa Mangoni, Cutolo, Carmen, Di Cesare, Ernesto, Splendiani, Alessandra, Giovagnoni, Andrea, Miele, Vittorio, Grassi, Roberto, Masciocchi, Carlo, Barile, Antonio
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 23.03.2022
MDPI
Subjects
Cancer
Contrast agents
contrast media
diffusion weighted imaging
Drug delivery systems
dynamic contrast enhancement
Fever
Hyperthermia
Inflammatory diseases
Magnetic fields
Magnetic resonance imaging
Nanomaterials
nanomedicine
Nanoparticles
Nanotechnology
Oncology
Physical properties
Review
nanomedicine
magnetic resonance imaging
nanoparticles
diffusion weighted imaging
dynamic contrast enhancement
contrast media
Online AccessGet full text

Cover

More Information
Summary:In the last decades, nanotechnology has been used in a wide range of biomedical applications, both diagnostic and therapeutic. In this scenario, imaging techniques represent a fundamental tool to obtain information about the properties of nanoconstructs and their interactions with the biological environment in preclinical and clinical settings. This paper reviews the state of the art of the application of magnetic resonance imaging in the field of nanomedicine, as well as the use of nanoparticles as diagnostic and therapeutic tools, especially in cancer, including the characteristics that hinder the use of nanoparticles in clinical practice.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
These authors contributed equally to this work.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers14071626